Argus Research analysts David Toung and Michelle Han downgraded Pfizer (NYSE: PFE) stock from Buy to Hold on Thursday, citing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE